NCT04989517View on ClinicalTrials.gov

Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

November 23, 2021

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2023

Conditions
Hidradenitis Suppurativa
Interventions
DRUG

AT193

Topical

Trial Locations (7)

2010

East Sydney Doctors, Darlinghurst

Holdsworth House Medical Practice, Darlinghurst

2217

Premier Specialists, Kogarah

2289

Novatrials, Kotara

2606

Woden Dermatology, Phillip

4102

Veracity Clinical Research, Woolloongabba

5074

North Eastern Health Specialists, Campbelltown

All Listed Sponsors
lead

Azora Therapeutics Australia Pty Ltd

INDUSTRY

NCT04989517 - Study of Efficacy and Safety of Investigational Treatment in Patients With Hidradenitis Suppurativa | Biotech Hunter | Biotech Hunter